Stemcell Holdings, Inc. primarily acts as a bridge between the US and Japan for biotech companies, particularly in the areas of licensing and patents. The company is engaged in the regenerative medicine-related business, providing technical assistance for culturing, storing, and delivering stem cells.
Focus Areas
Notable Investments
